603882 金域医学
已收盘 12-24 15:00:00
资讯
新帖
简况
每周股票复盘：金域医学（603882）梁耀铭解除650万股份质押
证券之星 · 11-16
每周股票复盘：金域医学（603882）梁耀铭解除650万股份质押
金域医学（603882）披露召开2025年第三季度业绩说明会公告，11月12日股价上涨0.8%
证券之星 · 11-12
金域医学（603882）披露召开2025年第三季度业绩说明会公告，11月12日股价上涨0.8%
金域医学（603882）股东梁耀铭质押650万股，占总股本1.4%
证券之星 · 11-08
金域医学（603882）股东梁耀铭质押650万股，占总股本1.4%
每周股票复盘：金域医学（603882）Q3净利增24.08%
证券之星 · 11-02
每周股票复盘：金域医学（603882）Q3净利增24.08%
股市必读：金域医学三季报 - 第三季度单季净利润同比增长24.08%
证券之星 · 10-31
股市必读：金域医学三季报 - 第三季度单季净利润同比增长24.08%
金域医学（603882）2025年三季报简析：净利润同比下降184.84%，公司应收账款体量较大
证券之星 · 10-31
金域医学（603882）2025年三季报简析：净利润同比下降184.84%，公司应收账款体量较大
金域医学(603882)9月30日股东户数4.17万户，较上期减少1.6%
证券之星 · 10-30
金域医学(603882)9月30日股东户数4.17万户，较上期减少1.6%
图解金域医学三季报：第三季度单季净利润同比增长24.08%
证券之星 · 10-30
图解金域医学三季报：第三季度单季净利润同比增长24.08%
金域医学新注册《基于广州生物信息HLA数据信息库的基因统计工具软件V1.0》项目的软件著作权
证券之星 · 10-30
金域医学新注册《基于广州生物信息HLA数据信息库的基因统计工具软件V1.0》项目的软件著作权
金域医学发布2025年前三季度业绩：惠民体系检测项目收入同比增长53.8%
证券日报 · 10-29
金域医学发布2025年前三季度业绩：惠民体系检测项目收入同比增长53.8%
每周股票复盘：金域医学（603882）完成工商变更登记
证券之星 · 10-26
每周股票复盘：金域医学（603882）完成工商变更登记
金域医学新注册《金域医学AI开放创新后台优惠券管理系统V1.0》等2个项目的软件著作权
证券之星 · 10-25
金域医学新注册《金域医学AI开放创新后台优惠券管理系统V1.0》等2个项目的软件著作权
金域医学（603882）披露完成工商变更登记并换发营业执照，10月23日股价上涨0.35%
证券之星 · 10-23
金域医学（603882）披露完成工商变更登记并换发营业执照，10月23日股价上涨0.35%
金域医学新注册《神免荧光照片批量命名工具软件V1.0》等2个项目的软件著作权
证券之星 · 10-14
金域医学新注册《神免荧光照片批量命名工具软件V1.0》等2个项目的软件著作权
金域医学新注册《基于django-amazeui框架和igv组件的HLA可视化生物信息数据分析工作软件V1.0》项目的软件著作权
证券之星 · 09-24
金域医学新注册《基于django-amazeui框架和igv组件的HLA可视化生物信息数据分析工作软件V1.0》项目的软件著作权
每周股票复盘：金域医学（603882）将召开2025年半年度业绩说明会
证券之星 · 09-21
每周股票复盘：金域医学（603882）将召开2025年半年度业绩说明会
金域医学新注册《用户管理系统V1.0》等3个项目的软件著作权
证券之星 · 09-19
金域医学新注册《用户管理系统V1.0》等3个项目的软件著作权
每周股票复盘：金域医学（603882）股东会通过取消监事会议案
证券之星 · 09-14
每周股票复盘：金域医学（603882）股东会通过取消监事会议案
金域医学涨7.94%，中国银河二周前给出“买入”评级
证券之星 · 09-08
金域医学涨7.94%，中国银河二周前给出“买入”评级
每周股票复盘：金域医学（603882）拟取消监事会
证券之星 · 09-07
每周股票复盘：金域医学（603882）拟取消监事会
加载更多
公司概况
公司名称：
广州金域医学检验集团股份有限公司
所属行业：
卫生
上市日期：
2017-09-08
主营业务：
广州金域医学检验集团股份有限公司的主营业务是第三方医学检验及病理诊断业务。公司的主要产品是医学检验及检验+AI技术。获得美国CAP、中国CNAS等国内外权威机构认证180项。
发行价格：
6.93
{"stockData":{"symbol":"603882","market":"SH","secType":"STK","nameCN":"金域医学","latestPrice":27.94,"timestamp":1766559600000,"preClose":27.84,"halted":0,"volume":2436070,"delay":0,"changeRate":0.0036,"floatShares":459999999,"shares":463000000,"eps":-1.1974,"marketStatus":"已收盘","change":0.1,"latestTime":"12-24 15:00:00","open":27.84,"high":27.99,"low":27.71,"amount":67910300,"amplitude":0.0101,"askPrice":27.94,"askSize":28,"bidPrice":27.93,"bidSize":224,"shortable":0,"etf":0,"ttmEps":-1.1974,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766626200000},"marketStatusCode":5,"adr":0,"adjPreClose":27.84,"symbolType":"stock","openAndCloseTimeList":[[1766539800000,1766547000000],[1766552400000,1766559600000]],"highLimit":30.62,"lowLimit":25.06,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":463258275,"isCdr":false,"pbRate":1.9,"roa":"--","roe":"--","epsLYR":-0.82,"committee":0.523166,"marketValue":12943000000,"turnoverRate":0.0053,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-12-29。","floatMarketCap":12856000000},"requestUrl":"/m/hq/s/603882","defaultTab":"news","newsList":[{"id":"2583591806","title":"每周股票复盘：金域医学（603882）梁耀铭解除650万股份质押","url":"https://stock-news.laohu8.com/highlight/detail?id=2583591806","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583591806?lang=zh_cn&edition=full","pubTime":"2025-11-16 02:19","pubTimestamp":1763230751,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，金域医学报收于30.49元，较上周的29.48元上涨3.43%。公司公告汇总广州金域医学检验集团股份有限公司于2025年11月10日接到控股股东、实际控制人梁耀铭先生通知，其质押给中信证券股份有限公司的6,500,000股公司股份已于2025年11月7日办理了解除质押手续。本次解除质押后，梁耀铭及其一致行动人累计质押股份31,580,000股，占其合计持股总数的19.14%，占公司总股本的6.82%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","SG9999001069.SGD","BK0284","BK0236","BK0042"],"gpt_icon":0},{"id":"2582720893","title":"金域医学（603882）披露召开2025年第三季度业绩说明会公告，11月12日股价上涨0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582720893","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582720893?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:13","pubTimestamp":1762956803,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，金域医学报收于30.15元，较前一交易日上涨0.8%，最新总市值为139.67亿元。该股当日开盘29.82元，最高30.19元，最低29.78元，成交额达1.38亿元，换手率为1.0%。公司近日发布公告称，广州金域医学检验集团股份有限公司将于2025年11月20日15:00-16:00通过网络文字互动方式召开2025年第三季度业绩说明会。本次说明会将就公司2025年第三季度的经营成果、财务状况等与投资者进行交流。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0236","BK0042","SG9999001069.SGD","BK0284"],"gpt_icon":0},{"id":"2581880409","title":"金域医学（603882）股东梁耀铭质押650万股，占总股本1.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581880409","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581880409?lang=zh_cn&edition=full","pubTime":"2025-11-08 00:23","pubTimestamp":1762532606,"startTime":"0","endTime":"0","summary":"证券之星消息，金域医学11月8日公开信息显示，股东梁耀铭向中信证券股份有限公司合计质押650.0万股，占总股本1.4%。质押详情见下表：截止本公告日，股东梁耀铭已累计质押股份2950.0万股，占其持股总数的39.76%，股东广州市圣域钫投资咨询合伙企业已累计质押股份858.0万股，占其持股总数的40.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110800000752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0284","SG9999001069.SGD","BK0236","603882"],"gpt_icon":0},{"id":"2580403418","title":"每周股票复盘：金域医学（603882）Q3净利增24.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580403418","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580403418?lang=zh_cn&edition=full","pubTime":"2025-11-02 09:52","pubTimestamp":1762048334,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，金域医学报收于29.9元，较上周的28.25元上涨5.84%。本周，金域医学10月30日盘中最高价报30.0元。本周关注点来自业绩披露要点：2025年第三季度归母净利润519.73万元，同比上升24.08%。股本股东变化截至2025年9月30日，金域医学股东户数为4.17万户，较6月30日减少676户，减幅1.6%。业绩披露要点2025年前三季度，金域医学实现营业收入45.38亿元，同比下降19.23%；归母净利润-7960.95万元，同比下降184.84%；扣非净利润-8424.97万元，同比下降208.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","SG9999001069.SGD","BK0236","BK0042","603882"],"gpt_icon":0},{"id":"2579868584","title":"股市必读：金域医学三季报 - 第三季度单季净利润同比增长24.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579868584","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579868584?lang=zh_cn&edition=full","pubTime":"2025-10-31 09:24","pubTimestamp":1761873854,"startTime":"0","endTime":"0","summary":"公司前三季度计提信用减值损失3.45亿元。公司公告汇总广州金域医学检验集团股份有限公司2025年第三季度报告2025年前三季度营业收入45.38亿元，同比下降19.23%；归母净利润-7960.95万元，同比下降184.84%；扣非净利润-8424.97万元，同比下降208.0%。第三季度营业收入15.41亿元，同比下降11.32%；归母净利润519.73万元，同比增长24.08%；扣非净利润1371.31万元，同比增长264.54%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100013981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882"],"gpt_icon":0},{"id":"2579109686","title":"金域医学（603882）2025年三季报简析：净利润同比下降184.84%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2579109686","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579109686?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:21","pubTimestamp":1761862916,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金域医学发布2025年三季报。截至本报告期末，公司营业总收入45.38亿元，同比下降19.23%，归母净利润-7960.95万元，同比下降184.84%。本报告期金域医学公司应收账款体量较大，当期应收账款占最新年报营业总收入比达53.23%。证券之星价投圈财报分析工具显示：业务评价：去年的净利率为-5.77%，算上全部成本后，公司产品或服务的附加值不高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100007945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882"],"gpt_icon":0},{"id":"2579118893","title":"金域医学(603882)9月30日股东户数4.17万户，较上期减少1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579118893","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579118893?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:24","pubTimestamp":1761816275,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学披露，截至2025年9月30日公司股东户数为4.17万户，较6月30日减少676.0户，减幅为1.6%。在医疗服务行业个股中，金域医学股东户数低于行业平均水平，截至9月30日，医疗服务行业平均股东户数为4.65万户。从股价来看，2025年6月30日至2025年9月30日，金域医学区间涨幅为3.85%，在此期间股东户数减少676.0户，减幅为1.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000032847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","SG9999001069.SGD","603882","BK0042","BK0236"],"gpt_icon":0},{"id":"2579018207","title":"图解金域医学三季报：第三季度单季净利润同比增长24.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579018207","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579018207?lang=zh_cn&edition=full","pubTime":"2025-10-30 02:45","pubTimestamp":1761763509,"startTime":"0","endTime":"0","summary":"证券之星消息，金域医学2025年三季报显示，前三季度公司主营收入45.38亿元，同比下降19.23%；归母净利润-7960.95万元，同比下降184.84%；扣非净利润-8424.97万元，同比下降208.0%；其中2025年第三季度，公司单季度主营收入15.41亿元，同比下降11.32%；单季度归母净利润519.73万元，同比上升24.08%；单季度扣非净利润1371.31万元，同比上升264.54%；负债率28.41%，投资收益365.76万元，财务费用-118.74万元，毛利率34.82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000002819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882"],"gpt_icon":0},{"id":"2579318499","title":"金域医学新注册《基于广州生物信息HLA数据信息库的基因统计工具软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2579318499","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579318499?lang=zh_cn&edition=full","pubTime":"2025-10-30 02:05","pubTimestamp":1761761130,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了《基于广州生物信息HLA数据信息库的基因统计工具软件V1.0》项目的软件著作权。今年以来金域医学新注册软件著作权81个，较去年同期增加了211.54%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目28次；财产线索方面有商标信息766条，专利信息216条，著作权信息165条；此外企业还拥有行政许可46个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000002334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0236","BK0284","603882","SG9999001069.SGD"],"gpt_icon":0},{"id":"2579875907","title":"金域医学发布2025年前三季度业绩：惠民体系检测项目收入同比增长53.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579875907","media":"证券日报 ","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579875907?lang=zh_cn&edition=full","pubTime":"2025-10-29 21:51","pubTimestamp":1761745860,"startTime":"0","endTime":"0","summary":"公司第三季度实现营业收入15.41亿元，同比下降11.32%；实现归属于上市公司股东的净利润519.73万元，同比增长24.08%；实现归属于上市公司股东的扣除非经常性损益的净利润0.14亿元，同比增长264.54%，实现2025年首次单季度净利润转正。 金域医学降本增效及数智化转型带来的成效也进一步释放，前三季度毛利率呈逐季增长的态势，公司的运营管理效率提升。截至三季度末，惠民体系项目收入同比增长53.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-29/doc-infvqmnc3220619.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-29/doc-infvqmnc3220619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0236","BK0284","603882","BK0042","SG9999001069.SGD"],"gpt_icon":0},{"id":"2578502533","title":"每周股票复盘：金域医学（603882）完成工商变更登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2578502533","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578502533?lang=zh_cn&edition=full","pubTime":"2025-10-26 03:00","pubTimestamp":1761418839,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，金域医学报收于28.25元，较上周的27.99元上涨0.93%。本周，金域医学10月24日盘中最高价报28.75元。本周关注点公司公告汇总：金域医学完成取消监事会及修订章程的工商变更登记并换发营业执照。公司公告汇总广州金域医学检验集团股份有限公司于2025年9月9日召开2025年第二次临时股东会，审议通过取消公司监事会并修订《公司章程》及相关议事规则的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","603882","BK0236","BK0042","BK0284"],"gpt_icon":0},{"id":"2578654177","title":"金域医学新注册《金域医学AI开放创新后台优惠券管理系统V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2578654177","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578654177?lang=zh_cn&edition=full","pubTime":"2025-10-25 01:54","pubTimestamp":1761328456,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了2个项目的软件著作权，包括《金域医学AI开放创新后台优惠券管理系统V1.0》、《数智病理读片会管理系统V1.0》等。今年以来金域医学新注册软件著作权80个，较去年同期增加了263.64%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目28次；财产线索方面有商标信息766条，专利信息216条，著作权信息165条；此外企业还拥有行政许可46个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102500001522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0284","SG9999001069.SGD","BK0236","603882"],"gpt_icon":0},{"id":"2577583360","title":"金域医学（603882）披露完成工商变更登记并换发营业执照，10月23日股价上涨0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577583360","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577583360?lang=zh_cn&edition=full","pubTime":"2025-10-23 22:18","pubTimestamp":1761229102,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，金域医学报收于28.41元，较前一交易日上涨0.35%，最新总市值为131.61亿元。公司近日发布公告称，广州金域医学检验集团股份有限公司已完成工商变更登记及《公司章程》备案手续，并取得广州市市场监督管理局换发的《营业执照》。此次变更涉及取消公司监事会并修订《公司章程》及相关议事规则，相关议案已于2025年9月9日经公司2025年第二次临时股东会审议通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300037761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0284","BK0042","SG9999001069.SGD","BK0236"],"gpt_icon":0},{"id":"2575281468","title":"金域医学新注册《神免荧光照片批量命名工具软件V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2575281468","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575281468?lang=zh_cn&edition=full","pubTime":"2025-10-14 01:57","pubTimestamp":1760378234,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了2个项目的软件著作权，包括《神免荧光照片批量命名工具软件V1.0》、《集团比对PT报告生成软件V1.0》等。今年以来金域医学新注册软件著作权76个，较去年同期增加了300%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目28次；财产线索方面有商标信息766条，专利信息215条，著作权信息164条；此外企业还拥有行政许可46个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400027268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","SG9999001069.SGD","BK0284","603882","BK0042"],"gpt_icon":0},{"id":"2569171029","title":"金域医学新注册《基于django-amazeui框架和igv组件的HLA可视化生物信息数据分析工作软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2569171029","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569171029?lang=zh_cn&edition=full","pubTime":"2025-09-24 02:08","pubTimestamp":1758650902,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了《基于django-amazeui框架和igv组件的HLA可视化生物信息数据分析工作软件V1.0》项目的软件著作权。今年以来金域医学新注册软件著作权74个，较去年同期增加了335.29%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目28次；财产线索方面有商标信息764条，专利信息213条，著作权信息164条；此外企业还拥有行政许可46个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092400000743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","SG9999001069.SGD","BK0284","603882","BK0236"],"gpt_icon":0},{"id":"2569245964","title":"每周股票复盘：金域医学（603882）将召开2025年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2569245964","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569245964?lang=zh_cn&edition=full","pubTime":"2025-09-21 03:19","pubTimestamp":1758395952,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，金域医学报收于30.69元，较上周的32.61元下跌5.89%。本周，金域医学9月15日盘中最高价报32.62元。本周关注点公司公告汇总：金域医学将于2025年9月19日召开2025年半年度业绩说明会。公司公告汇总广州金域医学检验集团股份有限公司将于2025年9月19日15:30-17:00参加2025年广东辖区上市公司投资者网上集体接待日，并召开2025年半年度业绩说明会。会议通过“全景路演”网站以网络文字互动方式举行。会后可通过“全景路演”网站查看会议情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0284","SG9999001069.SGD","BK0236","603882"],"gpt_icon":0},{"id":"2568402267","title":"金域医学新注册《用户管理系统V1.0》等3个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2568402267","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568402267?lang=zh_cn&edition=full","pubTime":"2025-09-19 01:47","pubTimestamp":1758217639,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了3个项目的软件著作权，包括《用户管理系统V1.0》、《96孔板自动排版软件V1.5》、《基于广州生物信息HLA数据信息库的批次与样本信息管理工具软件V1.0》等。今年以来金域医学新注册软件著作权73个，较去年同期增加了329.41%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091900001204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","SG9999001069.SGD","BK0284","BK0236","BK0042"],"gpt_icon":0},{"id":"2567589133","title":"每周股票复盘：金域医学（603882）股东会通过取消监事会议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2567589133","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567589133?lang=zh_cn&edition=full","pubTime":"2025-09-14 02:05","pubTimestamp":1757786715,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，金域医学报收于32.61元，较上周的30.86元上涨5.67%。本周关注点公司公告汇总：金域医学2025年第二次临时股东会审议通过取消公司监事会并修订公司章程的特别决议议案，获出席股东所持表决权2/3以上通过。公司公告汇总北京市中伦律师事务所就广州金域医学检验集团股份有限公司2025年第二次临时股东会出具法律意见书。本次会议无否决议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400000363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0042","BK0284","SG9999001069.SGD","603882"],"gpt_icon":0},{"id":"2565501557","title":"金域医学涨7.94%，中国银河二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2565501557","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565501557?lang=zh_cn&edition=full","pubTime":"2025-09-08 16:22","pubTimestamp":1757319773,"startTime":"0","endTime":"0","summary":"今日金域医学涨7.94%，收盘报33.31元。2025年8月25日，中国银河研究员程培,孟熙发布了对金域医学的研报《2025年中报业绩点评：Q2业绩仍受影响，数智化转型加速落地》，该研报对金域医学给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为21.41%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为国金证券的袁维。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800020521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601881","603882"],"gpt_icon":0},{"id":"2565510493","title":"每周股票复盘：金域医学（603882）拟取消监事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2565510493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565510493?lang=zh_cn&edition=full","pubTime":"2025-09-07 02:44","pubTimestamp":1757184254,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，金域医学报收于30.86元，较上周的31.95元下跌3.41%。本周，金域医学9月1日盘中最高价报32.68元。金域医学当前最新总市值142.96亿元，在医疗服务板块市值排名13/50，在两市A股市值排名1296/5152。上述议案旨在落实新《公司法》要求，完善公司治理结构，提升规范运作水平。会议采取现场与网络投票相结合方式，其中取消监事会及修订章程事项需经特别决议通过。董事会提请股东大会授权管理层办理工商变更等事宜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700000485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","SG9999001069.SGD","BK0284","BK0236","BK0042"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766602669451,"stockEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0464},{"period":"3month","weight":-0.0615},{"period":"6month","weight":-0.0305},{"period":"1year","weight":-0.0463},{"period":"ytd","weight":0.0375}],"compareEarnings":[{"period":"1week","weight":0.0183},{"period":"1month","weight":0.0272},{"period":"3month","weight":0.0227},{"period":"6month","weight":0.1509},{"period":"1year","weight":0.1613},{"period":"ytd","weight":0.1758}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州金域医学检验集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"41671人(较上一季度减少1.60%)","perCapita":"11042股","listingDate":"2017-09-08","address":"广东省广州市海珠区国际生物岛螺旋三路10号","registeredCapital":"46325万元","survey":" 广州金域医学检验集团股份有限公司的主营业务是第三方医学检验及病理诊断业务。公司的主要产品是医学检验及检验+AI技术。获得美国CAP、中国CNAS等国内外权威机构认证180项。","listedPrice":6.93},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金域医学,603882,金域医学股票,金域医学股票老虎,金域医学股票老虎国际,金域医学行情,金域医学股票行情,金域医学股价,金域医学股市,金域医学股票价格,金域医学股票交易,金域医学股票购买,金域医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}